Logo image of DRIO

DARIOHEALTH CORP (DRIO) Stock Fundamental Analysis

NASDAQ:DRIO - Nasdaq - US23725P2092 - Common Stock - Currency: USD

0.615  -0.03 (-3.92%)

Fundamental Rating

2

DRIO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 39 industry peers in the Health Care Technology industry. DRIO may be in some trouble as it scores bad on both profitability and health. DRIO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DRIO has reported negative net income.
DRIO had a negative operating cash flow in the past year.
DRIO had negative earnings in each of the past 5 years.
DRIO had a negative operating cash flow in each of the past 5 years.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

DRIO's Return On Assets of -40.22% is on the low side compared to the rest of the industry. DRIO is outperformed by 64.86% of its industry peers.
The Return On Equity of DRIO (-75.59%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -40.22%
ROE -75.59%
ROIC N/A
ROA(3y)-65.86%
ROA(5y)-75.2%
ROE(3y)-93.72%
ROE(5y)-101.81%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 -400 -600 -800

1.3 Margins

The Gross Margin of DRIO (39.90%) is worse than 72.97% of its industry peers.
In the last couple of years the Gross Margin of DRIO has grown nicely.
The Profit Margin and Operating Margin are not available for DRIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.88%
GM growth 5Y4.19%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

2

2. Health

2.1 Basic Checks

DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DRIO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DRIO has more shares outstanding
DRIO has a worse debt/assets ratio than last year.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

DRIO has an Altman-Z score of -6.02. This is a bad value and indicates that DRIO is not financially healthy and even has some risk of bankruptcy.
DRIO has a Altman-Z score of -6.02. This is in the lower half of the industry: DRIO underperforms 78.38% of its industry peers.
DRIO has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
DRIO's Debt to Equity ratio of 0.35 is in line compared to the rest of the industry. DRIO outperforms 43.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z -6.02
ROIC/WACCN/A
WACC13.18%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.57 indicates that DRIO should not have too much problems paying its short term obligations.
DRIO has a Current ratio (1.57) which is in line with its industry peers.
A Quick Ratio of 1.32 indicates that DRIO should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.32, DRIO perfoms like the industry average, outperforming 45.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.32
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

DRIO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.26%, which is quite impressive.
The Revenue has decreased by -2.11% in the past year.
The Revenue has been growing by 22.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)49.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.98%
Revenue 1Y (TTM)-2.11%
Revenue growth 3Y38.99%
Revenue growth 5Y22.46%
Sales Q2Q%111%

3.2 Future

Based on estimates for the next years, DRIO will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.17% on average per year.
Based on estimates for the next years, DRIO will show a very strong growth in Revenue. The Revenue will grow by 51.97% on average per year.
EPS Next Y49.5%
EPS Next 2Y22.75%
EPS Next 3Y17.17%
EPS Next 5YN/A
Revenue Next Year32.07%
Revenue Next 2Y32.47%
Revenue Next 3Y26.75%
Revenue Next 5Y51.97%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DRIO. In the last year negative earnings were reported.
Also next year DRIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as DRIO's earnings are expected to grow with 17.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.75%
EPS Next 3Y17.17%

More info and screens

0

5. Dividend

5.1 Amount

DRIO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DARIOHEALTH CORP

NASDAQ:DRIO (2/11/2025, 11:51:42 AM)

0.615

-0.03 (-3.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners27.12%
Inst Owner Change-31.95%
Ins Owners9.12%
Ins Owner Change1.08%
Market Cap20.97M
Analysts82.22
Price Target3.57 (480.49%)
Short Float %11.67%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.1%
Min EPS beat(2)10.33%
Max EPS beat(2)85.87%
EPS beat(4)4
Avg EPS beat(4)39.8%
Min EPS beat(4)10.33%
Max EPS beat(4)85.87%
EPS beat(8)6
Avg EPS beat(8)22.57%
EPS beat(12)8
Avg EPS beat(12)18.29%
EPS beat(16)9
Avg EPS beat(16)10.48%
Revenue beat(2)0
Avg Revenue beat(2)-12.06%
Min Revenue beat(2)-22.51%
Max Revenue beat(2)-1.62%
Revenue beat(4)0
Avg Revenue beat(4)-10.33%
Min Revenue beat(4)-22.51%
Max Revenue beat(4)-0.74%
Revenue beat(8)2
Avg Revenue beat(8)-9.23%
Revenue beat(12)4
Avg Revenue beat(12)-6.97%
Revenue beat(16)5
Avg Revenue beat(16)-6.23%
PT rev (1m)0%
PT rev (3m)-8.69%
EPS NQ rev (1m)-11.11%
EPS NQ rev (3m)-23.46%
EPS NY rev (1m)0%
EPS NY rev (3m)2.91%
Revenue NQ rev (1m)-0.32%
Revenue NQ rev (3m)-31.01%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.91
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.03
EYN/A
EPS(NY)-1
Fwd EYN/A
FCF(TTM)-1.15
FCFYN/A
OCF(TTM)-1.15
OCFYN/A
SpS0.68
BVpS1.72
TBVpS-0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.22%
ROE -75.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.9%
FCFM N/A
ROA(3y)-65.86%
ROA(5y)-75.2%
ROE(3y)-93.72%
ROE(5y)-101.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.88%
GM growth 5Y4.19%
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.04%
Cap/Sales 0.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.32
Altman-Z -6.02
F-Score4
WACC13.18%
ROIC/WACCN/A
Cap/Depr(3y)10.54%
Cap/Depr(5y)30.07%
Cap/Sales(3y)2.07%
Cap/Sales(5y)1.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.98%
EPS Next Y49.5%
EPS Next 2Y22.75%
EPS Next 3Y17.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.11%
Revenue growth 3Y38.99%
Revenue growth 5Y22.46%
Sales Q2Q%111%
Revenue Next Year32.07%
Revenue Next 2Y32.47%
Revenue Next 3Y26.75%
Revenue Next 5Y51.97%
EBIT growth 1Y-16.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.5%
EBIT Next 3Y23.26%
EBIT Next 5Y20.12%
FCF growth 1Y29.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.84%
OCF growth 3YN/A
OCF growth 5YN/A